GlassScriptPhysician profile
Surekha Perlman
NPI 1053349027
$1,427.32
in general payments reported to CMS, 2019-2025
17 companies · $157 in 2025
The $157 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $113 · 2020: $25.11 · 2021: $144 · 2022: $167 · 2023: $168 · 2024: $653 · 2025: $157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $748 · Travel and Lodging: $230.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $747.96 |
| Travel and Lodging | $230.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $593.85 | 2021-2025 | Minimed 780g |
| Vivus LLC | $161.81 | 2019-2024 | Qsymia |
| Novo Nordisk INC | $150.00 | 2019-2024 | Rybelsus, Ozempic, Wegovy |
| Amgen INC. | $95.72 | 2019-2025 | Evenity, Prolia |
| Xeris Pharmaceuticals, INC. | $54.73 | 2022-2025 | Gvoke Hypopen, Recorlev |
| Insulet Corporation | $52.65 | 2022-2025 | Omnipod |
| Abbvie INC. | $49.25 | 2024-2025 | |
| Dexcom, INC. | $40.43 | 2021-2024 | Dexcom G6 Transmitter |
| Tolmar, INC. | $39.72 | 2023-2025 | Jatenzo |
| Acella Pharmaceuticals, LLC | $39.07 | 2023-2024 | NP Thyroid 60 |
| Amneal Pharmaceuticals LLC | $31.90 | 2022 | |
| Lilly USA, LLC | $31.42 | 2019-2024 | Zepbound |
| Ultragenyx Pharmaceutical INC. | $24.86 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.93 | 2023 | Jardiance, Synjardy |
| Currax Pharmaceuticals LLC | $16.63 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tandem Diabetes Care, INC. | $14.93 | 2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Medtronic Minimed, INC. | $11.42 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Surekha Perlman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.